In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
July 4th, 2006 | 30 | No |
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 5.73 | -2.49 | -38.24 | 3 | 3 | 1 | 46 | 414.654 | 0 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
biological_use | Antiandrogenic | IBScreen Bioactives |
biological_use | Antiinflammatory | IBScreen Bioactives |
biological_use | Antineoplastic agent | IBScreen Bioactives IBScreen Bioactives |
biological_use | Antispermatogenic props. | IBScreen Bioactives |
PUBCHEM_PATENT_ID | EP0515386A1; EP0515386B1; US3960839; US3992315; US4246346; US5241063; US5274088; US5614408; US5958770; US5959180; WO1991010743A1; WO1998034471A1; WO1999043837A1; WO1999059578A1; WO2000061153A1 | IBM Patent Data |
mechanism | Inhibitor of spermatogenesis and sperm motility | IBScreen Bioactives IBScreen Bioactives |
mechanism | Inhibitor of testosterone release | IBScreen Bioactives |
mechanism | Regulations of TNFR I and II expression | IBScreen Bioactives |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
SGMR1-3-E | Sigma Opioid Receptor (cluster #3 Of 6), Eukaryotic | Eukaryotes | 207 | 0.31 | Binding ≤ 10μM |
ERG2-1-F | C-8 Sterol Isomerase (cluster #1 Of 2), Fungal | Fungi | 1170 | 0.28 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
SGMR1_HUMAN | Q99720 | Sigma Opioid Receptor, Human | 207 | 0.31 | Binding ≤ 1μM |
ERG2_YEAST | P32352 | C-8 Sterol Isomerase, Yeast | 1170 | 0.28 | Binding ≤ 10μM |
SGMR1_HUMAN | Q99720 | Sigma Opioid Receptor, Human | 207 | 0.31 | Binding ≤ 10μM |